Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
GR

Gerd Ruehter — 8 Patents

Eli Lilly: 6 patents #573 of 2,858Top 25%
Hamburg, DE: #474 of 5,803 inventorsTop 9%
Overall (All Time): #600,572 of 4,157,543Top 15%
8 Patents All Time
Gerd Ruehter has been granted 8 US patents while listed as an inventor at Eli Lilly. The first was granted in 2006 and the most recent in April 2019. Gerd Ruehter ranks #600,572 of 4,157,543 US inventors in our database (top 14.4%). Patent records list Gerd Ruehter in Hamburg, DE.

Patents per Year

Patents granted per year, 2006 to 2019Bar chart with a peak of 4 patents in 2007.peak 42006: 2 patents20062007: 4 patents20072017: 1 patents20172019: 1 patents2019

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10246413 Selective FKBP51 ligands for treatment of psychiatric disorders Steffen Gaali, Felix Hausch, Alexander Kirschner, Xixi Feng, Andreas Bracher 2019-04-02
9845292 Selective FKBP51 ligands for treatment of psychiatric disorders Steffen Gaali, Felix Hausch, Alexander Kirschner, Xixi Feng, Andreas Bracher 2017-12-19
7265127 β3 adrenergic agonists Jolie Anne Bastian, Daniel Jon Sall, Theo Schotten 2007-09-04 $45,006,000
7253181 β3 adrenergic agonists Jolie Anne Bastian, Daniel Jon Sall, Theo Schotten 2007-08-07 $201,033,000
7241772 β3 adrenergic agonists Jolie Anne Bastian, Daniel Jon Sall, Theo Schotten 2007-07-10 $166,479,000
7205407 3-Substituted oxindole β3 agonists Jolie Anne Bastian, Daniel Jon Sall, Theo Schotten 2007-04-17 $53,357,000
7125840 Substituted dipeptides as growth hormone secretagogues Jeffrey A. Dodge, Britta Evers, Louis Nickolaus Jungheim, Brian S. Muehl, Kenneth Jeff Thrasher 2006-10-24 $98,191,000
7071208 β3 Adrenergic agonists Jolie Anne Bastian, Daniel Jon Sall, Theo Schotten 2006-07-04